The weed-killing chemical at the heart of a $2 billion lawsuit may be linked to damaging fatty liver disease in humans


A Northern California couple was awarded more than $2 billion in a lawsuit against Monsanto, the agrochemical company now owned by Bayer.
The couple argued that a widely-used agricultural pesticide called glyphosate — found in Monsanto’s popular weed-killer, Roundup — was responsible for their non-Hodgkin’s lymphoma.
Two days later, a study suggested glyphosate is linked another major health risk, fatty liver disease, in humans.
Visit Business Insider’s homepage for more stories.

For more than three decades, Alva and Alberta Pilliod used weed-killer to tend their property in Northern California. The couple wasn’t told to wear gloves or other forms of protective clothing when spraying the product. Then they got sick.

In 2011, Alva was diagnosed with a type of blood cancer called non-Hodgkin’s lymphoma. Four year later, his wife, Alberta, received the same diagnosis.

Read more: The weed-killing chemical involved in a Monsanto lawsuit was found in Cheerios and Quaker Oats products. Here’s how worried you should be.

The couple believed their cancer was attributable to Roundup, a popular weed-killer whose active ingredient is glyphosate, a widely-used agricultural pesticide. On May 13, they were awarded more than $2 billion in damages in a lawsuit against Monsanto, the maker of Roundup, which is now owned by Bayer.

A jury ruled that Roundup was a “substantial factor” in causing the couple’s cancer, marking one of the first verdicts out of around 13,400 similar court cases lobbed against Monsanto.

The court cases track with a rise in scientific inquiry about the health risks of exposure to Roundup.

Two days after the Pilliod verdict, the journal Clinical Gastroenterology and Hepatology published a study that showed a possible link between glyphosate and another major health risk, fatty liver disease.

After examining the urine of nearly 100 patients with non-alcoholic fatty liver disease, …read more

Source:: Business Insider

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *